Helios and Matheson (HMNY), parent company of the popular movie subscription service, told regulators Monday that it wants to sell that much in stock and debt securities.
MoviePass exploded in popularity because of its low price. For just $10 a month, about the cost of a single movie ticket in most places, MoviePass subscribers can see one movie a day.
But the company loses money when its customers use a pass, because it must pay theaters for the tickets.
Previous SEC filings revealed that the company was burning through an average of $21.7 million every month operating MoviePass. In May it blew through $40 million.
Last month, Helios and Matheson said in another SEC document that it had only $18.5 million in cash on hand, plus $30.3 million in accounts receivable. It expected its June cash deficit would reach $45 million.
The service recently passed 3 million subscribers, and is trying to draw in more as part of the plan to stay afloat. Executives want to reach 5 million members by the end of the year, a number they say should help make the business profitable.
Hot Low Price Stocks To Buy For 2019: AirMedia Group Inc(AMCN)
Advisors' Opinion:- [By Paul Ausick]
AirMedia Group Inc. (NASDAQ: AMCN) posted a 52-week low of $1.04 after closing down 23% on Wednesday at $1.35. The 52-week high is $3.30. Volume was about 4 million, nearly 20 times the daily average of around 230,000 million shares. The Chinese outdoor advertising company said yesterday that it is terminating a potential go-private transaction.
Hot Low Price Stocks To Buy For 2019: McClatchy Company (MNI)
Advisors' Opinion:- [By Douglas A. McIntyre]
Several large newspaper chains will face the largest increases in newsprint prices in absolute dollars. These are Gannett (NYSE: GCI), tronc (NASDAQ: TRNC), hedge fund owned Digital First Media, which just laid off dozens of people in Denver and on the West Coast, Hearst, Advance Media, McClatchy (NYSE: MNI) and Gatehouse Media. Among them, they own most of the large newspapers in America and hundreds of newspapers in aggregate. Each of these companies has newsprint demand much larger than that of The Tampa Bay Times.
- [By Logan Wallace]
The McClatchy Company (NYSEAMERICAN:MNI) was the recipient of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 855,291 shares, a decrease of 4.6% from the April 13th total of 896,460 shares. Approximately 17.9% of the company’s stock are sold short. Based on an average trading volume of 11,764 shares, the short-interest ratio is currently 72.7 days.
- [By Shane Hupp]
Get a free copy of the Zacks research report on McClatchy (MNI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Douglas A. McIntyre]
Newspaper publisher McClatchy Co. (NYSE: MNI) made large staff cuts as ad revenue continues to fall. According to CNNMoney:
McClatchy, the publisher of more than two dozen daily newspapers across the country, will reduce its staff by approximately three and a half percent, cut expenses across the company, and implement other measures to save money, the company announced in an internal memo obtained by CNN on Tuesday.
Hot Low Price Stocks To Buy For 2019: Chesapeake Energy Corporation(CHK)
Advisors' Opinion:- [By Paul Ausick]
Here’s how share prices of the largest U.S. natural gas producers reacting to the latest report:
Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded up less than 0.1% to $79.26, in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded down about 2%, at $3.07 in a 52-week range of $2.53 to $5.87. EOG Resources Inc. (NYSE: EOG) traded up about 0.8% to $113.76. The 52-week range is $81.99 to $119.00.Furthermore, the United States Natural Gas ETF (NYSEARCA: UNG) traded down about 0.9%, at $22.41 in a 52-week range of $20.40 to $31.72.
- [By Paul Ausick]
Here’s how share prices of the largest U.S. natural gas producers reacted to today’s report:
Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded up about 0.1% to $74.35, in a 52-week range of $73.56 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded down about 0.7%, at $3.02 in a 52-week range of $2.53 to $6.59. EOG Resources Inc. (NYSE: EOG) traded down about 0.7% to $100.14. The 52-week range is $81.99 to $119.00.Furthermore, the United States Natural Gas ETF (NYSEARCA: UNG) traded down about 1.1%, at $22.96 in a 52-week range of $20.40 to $31.72.
- [By Logan Wallace]
Pennsylvania Trust Co increased its holdings in shares of Chesapeake Energy Co. (NYSE:CHK) by 101.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 101,025 shares of the oil and gas exploration company’s stock after buying an additional 50,800 shares during the period. Pennsylvania Trust Co’s holdings in Chesapeake Energy were worth $453,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
- [By Paul Ausick]
Here’s how share prices of the largest U.S. natural gas producers reacted to this latest report:
Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded up about 1.3%, at $80.98 in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded up about 2.0% to $3.33, in a 52-week range of $2.86 to $3.34. EOG Resources Inc. (NYSE: EOG) traded up about 1% to $118.92. The 52-week range is $81.99 to $119.71.The United States Natural Gas ETF (NYSEARCA: UNG) traded up about 2.4%, at $22.83 in a 52-week range of $20.40 to $31.72.
- [By Paul Ausick]
Chesapeake Energy Corp. (NYSE: CHK) traded down about 0.3% at $4.74 in a 52-week range of $2.53 to $5.20.
EOG Resources Inc. (NYSE: EOG) traded flat at $118.05. The 52-week range is $81.99 to $128.03.
Hot Low Price Stocks To Buy For 2019: Galmed Pharmaceuticals Ltd.(GLMD)
Advisors' Opinion:- [By Keith Speights]
That's exactly what happened this week with three small biotech stocks. Galmed Pharmaceuticals (NASDAQ:GLMD), Galectin Therapeutics (NASDAQ:GALT), and Eloxx Pharmaceuticals (NASDAQ:ELOX) soared on news that excited investors. Here's what drove these stocks higher -- and whether or not they're smart picks for investors now.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Galmed Pharmaceuticals (GLMD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By George Budwell]
Shares of the clinical-stage biotech Galmed Pharmaceuticals (NASDAQ:GLMD) are on absolute fire this morning, thanks to a positive midstage trial readout for its experimental nonalcoholic steatohepatitis (NASH) drug Aramchol. Specifically, the company reported that patients receiving the 400 mg dose of Aramchol exhibited a significant reduction in liver fat over the study period compared to those taking a placebo. Curiously, though, patients receiving the higher dose of 600 mg apparently only showed a statistically significant drop in liver fat relative to placebo patients in a post-hoc analysis, according to the press release.
- [By Shane Hupp]
Here are some of the media stories that may have effected Accern’s rankings:
Get Galmed Pharmaceuticals alerts: Galmed Pharmaceuticals’ (GLMD) CEO Allen Baharaff on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) What You Must Know About Galmed Pharmaceuticals Ltd's (NASDAQ:GLMD) Market Risks (finance.yahoo.com) Obeticholic Acid Market Analysis, Recent Trends and Regional Growth Forecast by Types, Applications and Economic … (theexpertconsulting.com) oholic Steatohepatitis (NASH) Market 2023: Know Marketing Channel Future Trend, Growth and Price with Future … (theexpertconsulting.com) Umbilical Cord Blood May Offer Early FH Diagnosis (medscape.com)A number of equities analysts have recently commented on GLMD shares. ValuEngine lowered shares of Galmed Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Wednesday, February 14th. Maxim Group set a $14.00 price target on shares of Galmed Pharmaceuticals and gave the stock a “buy” rating in a report on Wednesday, May 9th. Finally, HC Wainwright lifted their price target on shares of Galmed Pharmaceuticals from $18.00 to $24.00 and gave the stock a “buy” rating in a report on Monday, February 12th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $20.40.
Hot Low Price Stocks To Buy For 2019: E-House(China)
Advisors' Opinion:- [By ]
The world’s largest operating utility-scale solar projects are concentrated in China and India, according to IEEFA. Based on company and press reports, as well as its own estimates, those include:
RankingProject NameSize MWCountryProponent 1Tengger Desert Solar Park1,547ChinaChina National Grid Zhongwei Power Supply Co2Kurnool Ultra Mega Solar Park1,000IndiaAndhra Pradesh Solar Power Corporation Pvt Ltd3Datong Solar Power Top Runner Base1,000ChinaMultiple4Yanchi Ningxia Solar Park1,000ChinaHuawei Technologies Co5Longyangxia Dam Solar Park850ChinaState Power Investment Corporation (China)6Adani Kamuthi Solar Plant648IndiaAdani Green7Solar Star579U.S.BHE Renewables8Topaz Solar Farm550U.S.First Solar9Desert Sunlight Solar Farm550U.S.NextEra Energy, GE Energy Financial & Sumitomo10Nova Olinda Solar Farm292BrazilEnel Green PowerChina added 53 gigawatts of the 98 gigawatts of new solar capacity built last year, a 31 percent increase from the total 2017, IEEFA said, citing Bloomberg New Energy Finance data. Meanwhile, the per unit cost of electricity over the life of a generating asset fell 15 percent year-on-year to $86 a megawatt hour.
Hot Low Price Stocks To Buy For 2019: Insignia Systems, Inc.(ISIG)
Advisors' Opinion:- [By Ethan Ryder]
Insignia Systems, Inc. (NASDAQ:ISIG) major shareholder Air T. Inc acquired 16,879 shares of the company’s stock in a transaction dated Friday, June 1st. The shares were bought at an average price of $1.81 per share, for a total transaction of $30,550.99. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
No comments:
Post a Comment